Competitive Clinical Research Grant
Eli Lilly’s Competitive Clinical Research Grant funds investigator-led clinical studies aligned with Lilly’s scientific priorities, with projects selected through a competitive RFP process.
Funder: Eli Lilly and Company
Due Dates: Varies by RFP; check program page for current opportunities
Funding Amounts: Funding and/or study drug support; typical award size and duration not specified, varies by RFP.
Summary: Supports investigator-initiated clinical research aligned with Lilly’s scientific priorities, selected through a competitive RFP process.
Key Information: Applicants must manage all aspects of the study; eligibility and focus areas are defined per RFP.
Description
The Competitive Clinical Research Grant program by Eli Lilly and Company funds externally-initiated, designed, and sponsored clinical research projects that align with Lilly’s therapeutic interests. Funding is awarded through a public Request for Proposal (RFP) process, with each RFP outlining specific focus areas and timelines. Proposals undergo review by Lilly’s medical and scientific staff, and may also be reviewed by external committees. Approved research is managed entirely by the external investigator or institution, including study design, conduct, and regulatory compliance.
